Norris Medicines Limited (NORRIS.BO)
INR 19.21
(-1.99%)
INR 19.21
(-1.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 29.36 Million INR | -39.28% |
| 2022 | 48.35 Million INR | 30.22% |
| 2021 | 37.13 Million INR | 11.05% |
| 2020 | 33.43 Million INR | 8.25% |
| 2019 | 30.88 Million INR | -47.13% |
| 2018 | 58.41 Million INR | -7.39% |
| 2017 | 63.08 Million INR | -31.47% |
| 2016 | 92.04 Million INR | 1.88% |
| 2015 | 90.35 Million INR | -2.16% |
| 2014 | 92.35 Million INR | 132.22% |
| 2013 | 39.76 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 5.52 Million INR | -56.4% |
| 2023 Q1 | 5.84 Million INR | -49.64% |
| 2023 FY | 29.76 Million INR | -38.44% |
| 2023 Q4 | 12.66 Million INR | 113.93% |
| 2023 Q3 | 5.92 Million INR | 10.9% |
| 2023 Q2 | 5.33 Million INR | -8.58% |
| 2022 Q3 | 15.32 Million INR | 20.18% |
| 2022 FY | 48.35 Million INR | 30.22% |
| 2022 Q1 | 7.61 Million INR | 155.42% |
| 2022 Q2 | 12.75 Million INR | 67.39% |
| 2022 Q4 | 11.59 Million INR | -24.32% |
| 2021 FY | 37.13 Million INR | 11.05% |
| 2021 Q4 | 2.98 Million INR | -60.47% |
| 2021 Q3 | 7.54 Million INR | -21.84% |
| 2021 Q2 | 9.65 Million INR | -43.07% |
| 2021 Q1 | 16.95 Million INR | 420.25% |
| 2020 Q4 | 3.25 Million INR | -79.03% |
| 2020 FY | 33.43 Million INR | 8.25% |
| 2020 Q3 | 15.53 Million INR | 178.41% |
| 2020 Q2 | 5.58 Million INR | -38.4% |
| 2020 Q1 | 9.06 Million INR | 384.73% |
| 2019 Q4 | 1.86 Million INR | -80.19% |
| 2019 FY | 30.88 Million INR | -47.13% |
| 2019 Q1 | 13.37 Million INR | -41.01% |
| 2019 Q2 | 6.21 Million INR | -53.5% |
| 2019 Q3 | 9.43 Million INR | 51.73% |
| 2018 Q1 | 47.65 Million INR | 203.42% |
| 2018 FY | 58.41 Million INR | -7.39% |
| 2018 Q4 | 22.66 Million INR | 145.71% |
| 2018 Q3 | 9.22 Million INR | -22.53% |
| 2018 Q2 | 11.9 Million INR | -75.01% |
| 2017 Q2 | 12.13 Million INR | -33.19% |
| 2017 FY | 63.08 Million INR | -31.47% |
| 2017 Q1 | 18.16 Million INR | 49.74% |
| 2017 Q4 | 15.7 Million INR | -8.32% |
| 2017 Q3 | 17.13 Million INR | 41.13% |
| 2016 Q3 | 30.1 Million INR | 7.92% |
| 2016 Q2 | 27.89 Million INR | 27.98% |
| 2016 Q1 | 21.79 Million INR | 37.87% |
| 2016 FY | 92.04 Million INR | 1.88% |
| 2016 Q4 | 12.13 Million INR | -59.69% |
| 2015 FY | 90.35 Million INR | -2.16% |
| 2015 Q3 | 25.58 Million INR | -8.71% |
| 2015 Q2 | 28.02 Million INR | 31.45% |
| 2015 Q1 | 21.31 Million INR | -70.63% |
| 2015 Q4 | 15.8 Million INR | -38.21% |
| 2014 Q1 | 22.15 Million INR | 0.0% |
| 2014 FY | 92.35 Million INR | 132.22% |
| 2014 Q2 | 23.99 Million INR | 8.32% |
| 2014 Q3 | 23.68 Million INR | -1.28% |
| 2014 Q4 | 72.58 Million INR | 206.42% |
| 2013 FY | 39.76 Million INR | 0.0% |
| 2013 Q3 | 36.61 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 3.14 Million INR | -835.034% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | 73.728% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | 73.541% |
| Vasundhara Rasayans Limited | 207.68 Million INR | 85.862% |
| Sunil Healthcare Limited | 247.86 Million INR | 88.154% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -59.734% |
| MedPlus Health Services Limited | 12.33 Billion INR | 99.762% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 120.018% |
| Patidar Buildcon Limited | -26 Thousand INR | 113031.988% |
| Roopa Industries Limited | 72.95 Million INR | 59.752% |
| Smruthi Organics Limited | 324.76 Million INR | 90.959% |
| Trident Lifeline Limited | 119.08 Million INR | 75.343% |
| PANJON LTD. | 33.77 Million INR | 13.075% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 140.323% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | 79.236% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 264.864% |
| Anuh Pharma Limited | 1.6 Billion INR | 98.169% |
| Crestchem Limited | 51.53 Million INR | 43.027% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 495.026% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | 91.541% |
| Tyche Industries Limited | 290.84 Million INR | 89.905% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 95.948% |
| Trimurthi Limited | 1.95 Million INR | -1404.988% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | 90.225% |
| Zenlabs Ethica Limited | 147.75 Million INR | 80.128% |
| Vikram Thermo (India) Limited | 443.73 Million INR | 93.383% |
| ANG Lifesciences India Limited | 232.73 Million INR | 87.384% |
| Parmax Pharma Limited | 99.31 Million INR | 70.436% |
| Veerhealth Care Limited | 49.57 Million INR | 40.771% |
| Deccan Health Care Limited | 221.57 Million INR | 86.748% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | 91.884% |
| Makers Laboratories Limited | 308.54 Million INR | 90.484% |
| Lactose (India) Limited | 230.3 Million INR | 87.251% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 129.424% |
| Zenith Healthcare Limited | 46.17 Million INR | 36.409% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 85.943% |
| Bacil Pharma Limited | -19.95 Thousand INR | 147279.534% |
| PRAVEG LIMITED | 266.99 Million INR | 89.003% |
| Denis Chem Lab Limited | 596.24 Million INR | 95.075% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 97.957% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 97.351% |
| Colinz Laboratories Limited | 16.35 Million INR | -79.531% |
| Godavari Drugs Limited | 359.01 Million INR | 91.821% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 7332.098% |
| Zenotech Laboratories Limited | 337.19 Million INR | 91.292% |
| Panchsheel Organics Limited | 356.44 Million INR | 91.763% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | 95.645% |
| Vivanza Biosciences Limited | 19.38 Million INR | -51.454% |
| Phaarmasia Limited | 38.89 Million INR | 24.499% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 97.552% |
| Medi-Caps Limited | 68.09 Million INR | 56.878% |
| DECIPHER LABS LIMITED | 331.34 Million INR | 91.138% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 97.71% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | 95.908% |
| Mercury Laboratories Limited | 279.39 Million INR | 89.491% |
| Gennex Laboratories Limited | 276.99 Million INR | 89.4% |
| BDH Industries Limited | 175.55 Million INR | 83.275% |
| Coral Laboratories Limited | 332.39 Million INR | 91.166% |
| Concord Drugs Limited | 116.7 Million INR | 74.84% |
| Bharat Parenterals Limited | 989.46 Million INR | 97.033% |
| Beryl Drugs Limited | 108.5 Million INR | 72.939% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -193.037% |
| Evoq Remedies Limited | 47.43 Million INR | 38.099% |
| Add-Shop E-Retail Limited | 224.09 Million INR | 86.897% |
| Transchem Limited | -8.96 Million INR | 427.485% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | 24.598% |
| Parnax Lab Limited | 552.1 Million INR | 94.682% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | 55.52% |
| Kerala Ayurveda Limited | 447.69 Million INR | 93.441% |
| Cian Healthcare Limited | 113.16 Million INR | 74.054% |
| Trinity League India Limited | 1.23 Million INR | -2283.305% |
| Syschem (India) Limited | 569.04 Million INR | 94.84% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 172.118% |
| Natural Capsules Limited | 557.1 Million INR | 94.729% |
| Auro Laboratories Limited | 249.39 Million INR | 88.226% |